NCT05910580 Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
| NCT ID | NCT05910580 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Alcohol-Related Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2025-07-03 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2025-07-03 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test the effectiveness of evidence-based Screening, Brief Intervention, and Referral to Treatment (SBIRT) among adult patients who screen positive to one or more risky alcohol or substance use behaviors while seeking care at a sexual and reproductive health (SRH) clinic. The main questions it aims to answer are: * Does SBIRT impact patients' alcohol and substance use, SRH, mental health, physical health, quality of life, and wellbeing? * Does SBIRT effectiveness differ by ethnicity, socioeconomic status, age, gender, and urbanicity? * Does SBIRT effectiveness differ by delivery mode (in-person vs. telemedicine)? Participants will receive in-person and telemedicine SBIRT, or usual care. Participants will complete surveys at interviews at baseline, 30 days, and 3 months. Researchers will compare patients who received SBIRT to patients who receive usual care to see if patients who receive the SBIRT intervention have a greater reduction in negative outcomes as compared to those who receive usual care. In this setting, usual care consists of basic quantity and frequency questions asked inconsistently as part of the admission process and varying by provider, with no standardized approach to screening, treatment, follow-up, or referral.
Eligibility Criteria
Inclusion Criteria: * Over the age of 18 years * U.S. residing * Have internet access (own a computer or smart phone) * Screen positive to one or more risky alcohol and substance use behaviors as determined by our standardized abbreviated instruments Exclusion Criteria: * Not capable of communicating (reading, speaking, writing) in English or Spanish
Contact & Investigator
Kelli S Hall, MD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT05910580 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alcohol-Related Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05910580 currently recruiting?
Yes, NCT05910580 is actively recruiting participants. Contact the research team at ksh2110@cumc.columbia.edu for enrollment information.
Where is the NCT05910580 trial being conducted?
This trial is being conducted at Boston, United States, Marlborough, United States, Springfield, United States, Worcester, United States.
Who is sponsoring the NCT05910580 clinical trial?
NCT05910580 is sponsored by Emory University. The principal investigator is Kelli S Hall, MD at Columbia University. The trial plans to enroll 400 participants.